Ischemic heart disease still represents a large burden on individuals and health care
resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow …

Heart failure is a complex syndrome responsible for high rates of death and hospitalization.
Ischemic heart disease is one of the most frequent causes of heart failure and it is normally …

Atrial fibrillation (AF) is the most widely recognized arrhythmia. Systemic arterial
hypertension, diabetes, obesity, heart failure, and valvular heart diseases are major risk …

Magnesium is an essential mineral naturally present in the human body, where it acts as
cofactor in several enzymatic reactions. Magnesium is a key cardiovascular regulator, which …

Ischemic heart disease (IHD) has several risk factors, among which diabetes mellitus
represents one of the most important. In diabetic patients, the pathophysiology of myocardial …

Advanced heart failure (AdHF) represents a challenging aspect of heart failure patients.
Because of worsening clinical symptoms, high rates of re-hospitalization and mortality, AdHF …

Proper therapeutic management of patients with heart failure (HF) is a major challenge for
cardiologists. Current guidelines indicate to start therapy with angiotensin converting …

Heart failure is a multifaceted syndrome addressing for a high rate of death among the
general population. The common approach to this disease has been always based on the …

Heart failure (HF) is a clinical syndrome defined by specific symptoms and signs due to
structural and/or functional heart abnormalities, which lead to inadequate cardiac output …

目的: 达格列净属于钠-葡萄糖协同转运蛋白2 (SGLT-2) 抑制剂. 本研究评价达格列净治疗心力
衰竭的疗效和安全性. 方法: 根据协同检索策略, 检索Medline, Embase, 中文万方数据库, CNKI …